News Focus
News Focus
Post# of 257253
Next 10
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

Re: RockRat post# 106546

Tuesday, 11/08/2011 12:19:20 AM

Tuesday, November 08, 2011 12:19:20 AM

Post# of 257253
Regado provides additional phase-2b data on RB006/RB007 anticoagulant and reversing agent:

http://finance.yahoo.com/news/Regado-Biosciences-Inc-prnews-3336913480.html?x=0&.v=1

The main results from this phase-2b trial were presented at ACC in Mar 2011 (#msg-61433660).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now